Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Shares of FedEx Corporation FDX rose sharply in today's pre-market trading as the company posted stronger-than-expected results for its second quarter.

The company also announced that it has decided to pursue a full separation of FedEx Freight through the capital markets, creating a new publicly traded company.

FedEx shares jumped 8.7% to $299.80 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Aptose Biosciences Inc. APTO gained 80.5% to $0.3070 in pre-market trading after the company announced it was granted an extension to provide compliance evidence for a continued Nasdaq listing.
Psyence Biomedical Ltd. PBM gained 67.4% to $4.12 in pre-market trading fater jumping more than 60% on Thursday. The company announced it has entered into an IP licensing and mutual exclusivity agreement with Optimi Health Corp.
Ocean Biomedical, Inc. OCEA climbed 62.5% to $0.9576 in pre-market trading.
Nvni Group Limited NVNI gained 52.8% to $4.08 in pre-market trading after jumping 317% on Thursday.
Humacyte, Inc. HUMA rose 44.5% to $5.00 in pre-market trading as the company announced the FDA approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma.
Aadi Bioscience, Inc. AADI gained 35.3% to $3.14 in pre-market trading after the company secured $100 million PIPE financing and announced the sale of FYARRO for $100 million.
Xilio Therapeutics, Inc. XLO gained 26.9% to $1.19 in pre-market trading after the company announced 7.85 million of its shares was acquired by Gilead Sciences.
ZJK Industrial Co., Ltd. ZJK rose 17.4% to $8.78 in pre-market trading after dipping over 12% on Thursday.
Clearwater Paper Corporation CLW gained 11.8% to $27.62 in pre-market trading.

Losers

Molecular Templates, Inc. MTEM shares tumbled 49.5% to $0.1785 in pre-market trading after the company announced notice of delisting and failure to satisfy continued listing rules.
PainReform Ltd. PRFX declined 36.4% to $7.10 in pre-market trading after jumping around 410% on Thursday.
Cara Therapeutics, Inc. CARA shares fell 26.7% to $0.2998 in pre-market trading after jumping 56% on Thursday. Cara Therapeutics recently announced it entered into an all-stock merger with Tvardi Therapeutics.
Novo Nordisk A/S NVO fell 25.8% to $76.80 in pre-market trading. Novo Nordisk said CagriSema demonstrated weight loss in adults with obesity or overweight in the REDEFINE 1 trial.
XChange TEC.INC XHG shares dipped 25.2% to $0.9730 in pre-market trading after climbing 65% on Thursday.
Mobix Labs, Inc. MOBX fell 24.5% to $1.57 in today's pre-market trading after reporting third-quarter results.
Zoomcar Holdings, Inc. ZCAR dipped 23.6% to $1.94 in pre-market trading. Zoomcar said it launched Zoomcar Cabs, which are affordable car rentals with drivers as a new offering.
Mesoblast Limited MESO shares fell 18.1% to $13.72 in pre-market trading. Mesoblast shares jumped over 36% on Thursday after the company announced the FDA approved Ryoncilas the first mesenchymal stromal cell therapy in the United States.
Candel Therapeutics, Inc. CADL fell 13.1% to $8.66 in pre-market trading after jumping over 52% on Thursday.
Quantum Computing Inc. QUBT fell 11.1% to $13.46 in pre-market trading after declining 41% on Thursday.